469 related articles for article (PubMed ID: 14617689)
1. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
[TBL] [Abstract][Full Text] [Related]
2. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide induces apoptosis and reduces collagen I and pro-inflammatory cytokines expression in rat hepatic stellate cells.
Traister A; Breitman I; Bar-Lev E; Zvibel I; Harel A; Halpern Z; Oren R
Scand J Gastroenterol; 2005 Oct; 40(10):1226-34. PubMed ID: 16165703
[TBL] [Abstract][Full Text] [Related]
4. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse.
Anan A; Baskin-Bey ES; Isomoto H; Mott JL; Bronk SF; Albrecht JH; Gores GJ
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G709-16. PubMed ID: 16798723
[TBL] [Abstract][Full Text] [Related]
6. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
7. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
8. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
[TBL] [Abstract][Full Text] [Related]
9. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.
Canbay A; Higuchi H; Bronk SF; Taniai M; Sebo TJ; Gores GJ
Gastroenterology; 2002 Oct; 123(4):1323-30. PubMed ID: 12360492
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells.
Trebicka J; Hennenberg M; Odenthal M; Shir K; Klein S; Granzow M; Vogt A; Dienes HP; Lammert F; Reichen J; Heller J; Sauerbruch T
J Hepatol; 2010 Oct; 53(4):702-12. PubMed ID: 20633948
[TBL] [Abstract][Full Text] [Related]
13. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression.
Canbay A; Feldstein AE; Higuchi H; Werneburg N; Grambihler A; Bronk SF; Gores GJ
Hepatology; 2003 Nov; 38(5):1188-98. PubMed ID: 14578857
[TBL] [Abstract][Full Text] [Related]
14. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis.
Patella S; Phillips DJ; Tchongue J; de Kretser DM; Sievert W
Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G137-44. PubMed ID: 16123203
[TBL] [Abstract][Full Text] [Related]
15. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
Gonzalo T; Beljaars L; van de Bovenkamp M; Temming K; van Loenen AM; Reker-Smit C; Meijer DK; Lacombe M; Opdam F; Kéri G; Orfi L; Poelstra K; Kok RJ
J Pharmacol Exp Ther; 2007 Jun; 321(3):856-65. PubMed ID: 17369283
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis.
Lee TY; Lee KC; Chang HH
Apoptosis; 2010 Aug; 15(8):904-14. PubMed ID: 20446039
[TBL] [Abstract][Full Text] [Related]
18. Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation.
Osawa Y; Seki E; Adachi M; Taura K; Kodama Y; Siegmund SV; Schwabe RF; Brenner DA
Liver Int; 2006 Nov; 26(9):1138-47. PubMed ID: 17032415
[TBL] [Abstract][Full Text] [Related]
19. [Effect of antioxidant on hepatic stellate cell proliferation and apoptosis during recovery from liver fibrosis].
Shen XH; Cheng WF; Li XH; Xie LM; Sun J; Li F; Ma L
Wei Sheng Yan Jiu; 2005 Mar; 34(2):194-6. PubMed ID: 15952662
[TBL] [Abstract][Full Text] [Related]
20. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]